Biocomposites announced expanded approval in India for STIMULAN® Rapid Cure to be mixed with antimicrobials to treat infection Biocomposites announces the expanded approval for STIMULAN® Rapid Cure in India. The approval from India’s Central Drugs Standard Control Organisation (CDSCO) allows STIMULAN® Rapid Cure to be mixed with a wider variety of antibiotics than before, including in combination, […]
People in Europe and the US rarely pay for prescription drugs out of their own pockets. In Europe, their national health services almost always pick up the tab – even if some people have to contribute by way of a prescription charge. In the US, the health insurer normally foots the bill. But things have […]
What an incredible few days at Jefferies & London Life Science Week! 🎉 A huge thank you to Jefferies, the BioIndustry Association (BIA), MedCity, and London & Partners for hosting this goliath event. It gets bigger, better and more impactful every year, and we’re proud to be part of it. We are glad so many […]
You have probably already seen the news: not one but two major European life science funds have closed in the last week – collectively raising a massive €1.15 billion! Last Friday (November 14), leading European life sciences venture capital firm Medicxi announced it had closed its €500 million Medicxi V fund. And on Monday, (November […]
When and Where 📍 3rd December, 1 Wimpole Street, London Genesis 2025 is a fantastic opportunity for our ecosystem to connect, collaborate, and create returns for innovators, investors, patients, and society. The Optimum team will be in attendance, so if you would like to meet with us please do reach out. If you register with […]
